scriptaid has been researched along with Disease Models, Animal in 9 studies
scriptide: provokes translocation of GLUT4 to increase glucose uptake; structure in first source
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the role of Scriptaid in reducing brain injury after intracerebral hemorrhage (ICH) in mice." | 7.88 | Histone Deacetylase Inhibitor Scriptaid Alleviated Neurological Dysfunction after Experimental Intracerebral Hemorrhage in Mice. ( Gu, Y; Jiang, H; Lei, Y; Ni, W; Su, J; Yang, H; Zhou, L, 2018) |
| "SAHA, Valproic Acid, Scriptaid, MS275 and LBH589 were combined with Delta24-RGD in fourteen distinct GSCs." | 5.42 | The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells. ( Berghauser Pont, LM; de Vrij, J; Dirven, CM; Kaufmann, JK; Kleijn, A; Kloezeman, JJ; Lamfers, ML; Leenstra, S; van den Bossche, W, 2015) |
| "To investigate the role of Scriptaid in reducing brain injury after intracerebral hemorrhage (ICH) in mice." | 3.88 | Histone Deacetylase Inhibitor Scriptaid Alleviated Neurological Dysfunction after Experimental Intracerebral Hemorrhage in Mice. ( Gu, Y; Jiang, H; Lei, Y; Ni, W; Su, J; Yang, H; Zhou, L, 2018) |
| "These findings indicate that Scriptaid is safe and can alleviate brain injury after ICH, thereby providing a foundation for the pharmacological action of Scriptaid in the treatment of brain injury after ICH." | 1.56 | Pharmacokinetics and Acute Toxicity of a Histone Deacetylase Inhibitor, Scriptaid, and its Neuroprotective Effects in Mice After Intracranial Hemorrhage. ( Gao, X; Gu, Y; Jiang, H; Lei, Y; Ni, W; Su, J; Yang, H, 2020) |
| "SAHA, Valproic Acid, Scriptaid, MS275 and LBH589 were combined with Delta24-RGD in fourteen distinct GSCs." | 1.42 | The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells. ( Berghauser Pont, LM; de Vrij, J; Dirven, CM; Kaufmann, JK; Kleijn, A; Kloezeman, JJ; Lamfers, ML; Leenstra, S; van den Bossche, W, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Yang, H | 3 |
| Gao, X | 2 |
| Su, J | 3 |
| Jiang, H | 3 |
| Lei, Y | 3 |
| Ni, W | 3 |
| Gu, Y | 3 |
| Wei, P | 1 |
| Li, S | 1 |
| Zhou, L | 2 |
| Berghauser Pont, LM | 1 |
| Kleijn, A | 1 |
| Kloezeman, JJ | 1 |
| van den Bossche, W | 1 |
| Kaufmann, JK | 1 |
| de Vrij, J | 1 |
| Leenstra, S | 1 |
| Dirven, CM | 1 |
| Lamfers, ML | 1 |
| Qing, H | 2 |
| Aono, J | 1 |
| Findeisen, HM | 2 |
| Jones, KL | 2 |
| Heywood, EB | 2 |
| Bruemmer, D | 2 |
| Gizard, F | 1 |
| Zhao, Y | 1 |
| Cohn, D | 1 |
| Wang, G | 1 |
| Jiang, X | 1 |
| Pu, H | 1 |
| Zhang, W | 1 |
| An, C | 1 |
| Hu, X | 1 |
| Liou, AK | 1 |
| Leak, RK | 1 |
| Gao, Y | 1 |
| Chen, J | 1 |
| Corcoran, LJ | 1 |
| Mitchison, TJ | 1 |
| Liu, Q | 1 |
9 other studies available for scriptaid and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Pharmacokinetics and Acute Toxicity of a Histone Deacetylase Inhibitor, Scriptaid, and its Neuroprotective Effects in Mice After Intracranial Hemorrhage.
Topics: Animals; Brain; Disease Models, Animal; Female; Histone Deacetylase Inhibitors; Hydroxylamines; Intr | 2020 |
HDAC inhibition reduces white matter injury after intracerebral hemorrhage.
Topics: Animals; Blood Coagulation Factors; Case-Control Studies; Cerebral Hemorrhage; Coculture Techniques; | 2021 |
Histone Deacetylase Inhibitor Scriptaid Alleviated Neurological Dysfunction after Experimental Intracerebral Hemorrhage in Mice.
Topics: Animals; Basal Ganglia; Brain; Brain Edema; Brain Injuries; Cerebral Hemorrhage; Disease Models, Ani | 2018 |
The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells.
Topics: Adenoviridae; Animals; Apoptosis; Astrocytes; Autophagy; Brain Neoplasms; Cell Survival; Disease Mod | 2015 |
Differential Regulation of Telomerase Reverse Transcriptase Promoter Activation and Protein Degradation by Histone Deacetylase Inhibition.
Topics: Animals; Cells, Cultured; Cellular Senescence; Disease Models, Animal; Gene Expression Regulation; H | 2016 |
Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition.
Topics: Acetylation; Animals; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cells, Cultured; Chromati | 2011 |
Scriptaid, a novel histone deacetylase inhibitor, protects against traumatic brain injury via modulation of PTEN and AKT pathway : scriptaid protects against TBI via AKT.
Topics: Animals; Blotting, Western; Brain Injuries; Disease Models, Animal; Fluorescent Antibody Technique; | 2013 |
A novel action of histone deacetylase inhibitors in a protein aggresome disease model.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Fractionation; Chlorocebus aethiops; COS Cells; Disease | 2004 |